DUBLIN--(BUSINESS WIRE)--The "Global In-vitro Diagnostics Market - Segmented by Technique, Products, Usability, Application, End Users, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global in-vitro diagnostics market is expected to register a CAGR of 5.5% during the forecast period of 2018-2023.
Advanced Technologies Spurring the IVD Market
The field of in-vitro diagnostics has witnessed several changes and additions to its gamut of offerings in the recent past. There has been a paradigm shift from traditional diagnostics to a new generation diagnostics that work on gene level. This was possible due to the inclusion of advanced technology, such as genetic testing, molecular diagnostics, Polymerase Chain Reaction (PCR), and Next-Generation Sequencing (NGS).
Fast turnaround, reliability, user-friendliness, and predictability of predisposed diseases are few significant qualities, which helped these technologies attain their share in major offerings of diagnosis providers around the world. Increasing demand from the educated public for more information about their predisposition for serious diseases, and how these potential illnesses can be detected at an early stage, is driving the market for in-vitro diagnostics.
High prevalence of chronic and infectious diseases, increasing use of point of care (POC) diagnostics, and surging number of private hospitals and independent testing laboratories are some of the other factors contributing to the growth of the market.
Other Key Highlights
-
Cumbersome Reimbursement Procedure - A Major Restraint
- Asia-Pacific to be Lucrative
Notable Developments in the Market
- Roche acquired Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
- Biomerieux
- Danaher Corporation
- Roche Diagnostics
- Becton
- Dickinson and Company
- Bio-Rad Laboratories Inc.
- Abbott Laboratories
- Bayer AG
- Arkray Inc.
- Sysmex Corporation
- Johnson & Johnson
- Siemens AG
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/fx2rl7/global_invitro?w=4
